News & Events

For Immediate Release

Bookmark & Share
Contact: Kathryn Ryan, 914-740-2100,
Longer Duration of Untreated Childhood Schizophrenia-Spectrum Psychosis Predicts Poorer Outcomes

New Rochelle, NY, August 2, 2016—A review of 35 studies of early-onset schizophrenia-spectrum psychosis (EOS) identified the most common psychotic symptoms and the disorders that most often co-occur in children and adolescents with EOS. The longer the psychosis goes untreated, the lower the predicted functional improvement, according to a study published in Journal of Child and Adolescent Psychopharmacology, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the Journal of Child and Adolescent Psychopharmacology website until September 2, 2016.

In “Clinical Characteristics and Predictors of Outcome of Schizophrenia-Spectrum Psychosis in Children and Adolescents: A Systematic Review,” Marie Stentebjerg-Olesen, MD, Anne Pagsberg, MD, and Pia Jeppesen, MD, Mental Health Services, the Capital Region of Denmark and University of Copenhagen; Anders Fink-Jensen, MD, Copenhagen University Hospital and University of Copenhagen, and Christoph Correll, MD, North Shore-Long Island Jewish Health System and School of Medicine and Albert Einstein College of Medicine, New York, report that although the children's and teen's symptoms and functioning improved significantly over time, they experienced frequent pre- and co-morbid conditions. Poorer adjustment to pre-morbid conditions was also associated with worse EOS outcomes.

About the Journal
Journal of Child and Adolescent Psychopharmacology is an authoritative peer-reviewed journal published ten times per year online with open access options and in print. The Journal is dedicated to child and adolescent psychiatry and behavioral pediatrics, covering clinical and biological aspects of child and adolescent psychopharmacology and developmental neurobiology. Complete tables of content and a sample issue may be viewed on the Journal of Child and Adolescent Psychopharmacology website.

About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Cyberpsychology, Behavior, and Social Networking, Games for Health Journal, and Violence and Gender. Its biotechnology trade magazine, GEN (Genetic Engineering & Biotechnology News), was the first in itss field and is today the industry’s most widely read publication worldwide. A complete list of the firm’s 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.